Potential new role of the GHSR-1a-mediated signaling pathway in cardiac remodeling after myocardial infarction (Review)

Oncology Letters

Volumn 8, Issue 3, 2014, Pages 969-971

  Yuan, Ming Jie ^a   Huang, He ^a   Huang, Cong Xin ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Cardiac remodeling; Ghrelin; GHSR 1a; Myocardial infarction

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GHRELIN RECEPTOR; GROWTH HORMONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SOMATOMEDIN C;

APOPTOSIS; CARDIAC REMODELING; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; ENZYME ACTIVITY; HEART INFARCTION; HUMAN; INFLAMMATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84904266974     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2245     Document Type: Review

References (35)

1. Dorn GW: Novel pharmacotherapies to abrogate postinfarction ventricular remodeling. Nat Rev Cardiol 6: 283-291, 2009.
2. Deboer MD: The use of ghrelin and ghrelin receptor agonists as a treatment for animal models of disease: efficacy and mechanism. Curr Pharm Des 18: 4779-4799, 2012.
3. Strasser F: Clinical application of ghrelin. Curr Pharm Des 18: 4800-4812, 2012.
4. Kojima M, Hosoda H, Date Y, et al: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402: 656-660, 1999.
5. Isgaard J: Ghrelin and the cardiovascular system. Endocr Dev 25: 83-90, 2013.
6. Baatar D, Patel K and Taub DD: The effects of ghrelin on inflammation and the immune system. Mol Cell Endocrinol 340: 44-58, 2011.
7. Repaci A, Gambineri A, Pagotto U and Pasquali R: Ghrelin and reproductive disorders. Mol Cell Endocrinol 340: 70-79, 2011.
8. Yang J, Liu GQ, Wei R, et al: Ghrelin promotes differentiation of human embryonic stem cells into cardiomyocytes. Acta Pharmacol Sin 32: 1239-1245, 2011.
9. Huang CX, Yuan MJ, Huang H, et al: Ghrelin inhibits post-infarct myocardial remodeling and improves cardiac function through anti-inflammation effect. Peptides 30: 2286-2291, 2009.
10. Kishimoto I, Tokudome T, Hosoda H, et al: Ghrelin and cardiovascular diseases. J Cardiol 59: 8-13, 2012.
11. Xu X, Ding F, Pang J, et al: Chronic administration of hexarelin attenuates cardiac fibrosis in the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol 303: H703-H711, 2012.
12. Mao Y, Tokudome T, Otani K, et al: Ghrelin prevents incidence of malignant arrhythmia after acute myocardial infarction through vagal afferent nerves. Endocrinology 153: 3426-3434, 2012.
13. Yuan MJ, Huang CX, Tang YH, et al: A novel peptide ghrelin inhibits neural remodeling after myocardial infarction in rats. Eur J Pharmacol 618: 52-57, 2009.
14. Gnanapavan S, Kola B, Bustin SA, et al: The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metabol 87: 2988, 2002.
15. Gaytan F, Barreiro ML, Caminos JE, et al: Expression of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in normal human testis and testicular tumors. J Clin Endocrinol Metab 89: 400-409, 2004.
16. Ghelardoni S, Carnicelli V, Frascarelli S, et al: Ghrelin tissue distribution: comparison between gene and protein expression. J Endocrinol Invest 29: 115-121, 2006.
17. Iglesias MJ, Pineiro R, Blanco M, et al: Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes. Cardiovasc Res 62: 481-488, 2004.
18. Nishi Y, Yoh J, Hiejima H and Kojima M: Structures and molecular forms of the ghrelin-family peptides. Peptides 32: 2175-2182, 2011.
19. Chen C, Wu D, Clarke IJ: Signal transduction systems employed by synthetic GH-releasing peptides in somatotrophs. J Endocrinol 148: 381-386, 1996.
20. Lodeiro M, Theodoropoulou M, Pardo M, et al: c-Src regulates Akt signaling in response to ghrelin via beta-arrestin signaling-independent and-dependent mechanisms. PLoS One 4: e4686, 2009.
21. Camiña JP, Lodeiro M, Ischenko O, et al: Stimulation by ghrelin of p42/p44 mitogen-activated protein kinase through the GHS-R1a receptor: role of G-proteins and beta-arrestins. J Cell Physiol 213: 187-200, 2007.
22. Wang Y, Narsinh K, Zhao L, et al: Effects and mechanisms of ghrelin on cardiac microvascular endothelial cells in rats. Cell Biol Int 35: 135-140, 2011.
23. Chen JH, Huang SM, Chen CC, et al: Ghrelin induces cell migration through GHS-R, CaMKII, AMPK, and NF-κB signaling pathway in glioma cells. J Cell Biochem 112: 2931-2941, 2011.
24. Holliday ND, Holst B, Rodionova EA, et al: Importance of constitutive activity and arrestin-independent mechanisms for intracellular trafficking of the ghrelin receptor. Mol Endocrinol 21: 3100-3112, 2007.
25. Iantorno M, Chen H, Kim JA, et al: Ghrelin has novel vascular actions that mimic PI 3-kinase-dependent actions of insulin to stimulate production of NO from endothelial cells. Am J Physiol Endocrinol Metab 292: E756-E764, 2007.
26. Xu X, Jhun BS, Ha CH and Jin ZG: Molecular mechanisms of ghrelin-mediated endothelial nitric oxide synthase activation. Endocrinology 149: 4183-4192, 2008.
27. Chen X, Chen Q, Wang L and Li G: Ghrelin induces cell migration through GHSR1a-mediated PI3K/Akt/eNOS/NO signaling pathway in endothelial progenitor cells. Metabolism 62: 743-752, 2013.
28. Lacerda-Miranda G, Soares VM, Vieira AK, et al: Ghrelin signaling in heart remodeling of adult obese mice. Peptides 35: 65-73, 2012.
29. Ma Y, Zhang L, Edwards JN, et al: Growth hormone secretagogues protect mouse cardiomyocytes from in vitro ischemia/reperfusion injury through regulation of intracellular calcium. PLoS One 7: e35265, 2012.
30. Kanashiro-Takeuchi RM, Takeuchi LM, Rick FG, et al: Activation of growth hormone releasing hormone (GHRH) receptor stimulates cardiac reverse remodeling after myocardial infarction (MI). Proc Natl Acad Sci USA 109: 559-563, 2012.
31. Kanashiro-Takeuchi RM, Tziomalos K, Takeuchi LM, et al: Cardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarction. Proc Natl Acad Sci USA 107: 2604-2609, 2010.
32. Casanueva FF, Camina JP, Carreira MC, et al: Growth hormone-releasing hormone as an agonist of the ghrelin receptor GHS-R1a. Proc Natl Acad Sci USA 105: 20452-20457, 2008.
33. Beiras-Fernandez A, Kreth S, Weis F, et al: Altered myocardial expression of ghrelin and its receptor (GHSR-1a) in patients with severe heart failure. Peptides 31: 2222-2228, 2010.
34. Buss SJ, Riffel JH, Malekar P, et al: Chronic Akt blockade aggravates pathological hypertrophy and inhibits physiological hypertrophy. Am J Physiol Heart Circ Physiol 302: H420-H430, 2012.
35. Chen LL, Zhu TB, Yin H, et al: Inhibition of MAPK signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through reduction of inflammation. Mol Biol Rep 37: 3067-3072, 2010. 1. Moding EJ, Kastan MB and Kirsch DG: Strategies for optimizing the response of cancer and normal tissues to radiation. Nat Rev Drug Discov 12: 526-542, 2013.